Pilot Physiological Evaluation of an Investigational Mask with Expiratory Washout.

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorFisher and Paykel Healthcare

About this trial

The goal of this pilot randomized cross-over study is to compare the effect of a full-face mask with expiratory washout to a conventional full face mask on non-invasive ventilation (NIV) in patients with acute hypercapnic, and acute hypoxemic, respiratory failure. The main questions it aims to answer are:

* Does a mask with expiratory washout improve minute ventilation in patients using non-invasive ventilation compared with a conventional single-limb NIV mask * How does a mask with expiratory washout affect respiratory variables compared with a dual-limb NIV mask.

Participants already prescribed NIV will undergo 3 arms of the investigation in a randomized order:

* Single-limb NIV with investigation mask (with expiratory washout) * Single-limb NIV with conventional mask * Dual-limb NIV with conventional mask

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

No indication of intubation upon evaluation by physician in the next 2 hours

Fits the investigational mask

Patients hospitalized with acute respiratory failure (ARF) stabilized and tolerating NIV or;

Acute hypercapnic respiratory failure with hypercapnia and acidosis (Partial pressure of arterial carbon dioxide (PaCO2) > 45 millimeters of mercury (mmHg) and pH < 7.38) or

Disqualifiers

Refusal to participate in the study

Inability to provide informed consent

Infectious isolation

Facial deformity, burns or morphology that prevents adequate mask placement

Trial design

Design model

Crossover

Treatments tested in this trial

  • Investigational full-face mask with expiratory washout

    Device

    With cross-over in randomized order, mask worn for 30 minutes with prescribed single-limb non-invasive ventilation

  • Conventional full-face mask - single-limb

    Device

    With cross-over in randomized order, conventional mask such as RT077, worn for 30 minutes with prescribed single-limb non-invasive ventilation

  • Conventional full-face mask - dual-limb

    Device

    With cross-over in randomized order, conventional mask such as RT076, worn for 30 minutes with prescribed dual-limb non-invasive ventilation

Treatment groups

32 Participants
are divided into 3 treatment groups
Group A: Single-limb non-invasive ventilation with expiratory washoutExperimental treatment 1 intervention
Group B: Single-limb non-invasive ventilationActive comparator 1 intervention
Group C: Dual-limb non-invasive ventilationActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Minute Ventilation

Variations of the minute ventilation in the three different arms (Investigational mask, single-limb conventional, dual-limb conventional)

Time frame
Recorded at baseline and the end of each 30-minute period of non-invasive ventilation over 1 hour and 30 minutes of data measurement

Secondary outcomes

1

Tidal Volume

Changes in tidal volume over the three different arms

Time frame
Recorded at baseline and the end of each 30-minute period of non-invasive ventilation over 1 hour and 30 minutes of data measurement
2

Respiratory Rate

Changes in respiratory rate over the three different arms

Time frame
Recorded at baseline and the end of each 30-minute period of non-invasive ventilation over 1 hour and 30 minutes of data measurement
3

Blood gases

Changes in blood gas values over the three different arms

Time frame
Recorded at baseline and the end of each 30-minute period of non-invasive ventilation over 1 hour and 30 minutes of data measurement
4

Dyspnoea Score

Changes in dyspnea score over the three different arms. Dyspnea measured with the modified Borg dyspnea score, which utilizes a scale of 0 to 10 where 0 represents no dyspnea and 10 represents maximal dyspnea.

Time frame
Recorded at baseline and the end of each 30-minute period of non-invasive ventilation over 1 hour and 30 minutes of data measurement

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Fisher and Paykel Healthcare

Lead sponsor

Institut universitaire de cardiologie et de pneumologie de Québec, University Laval

Collaborator

Centre hospitalier de l'Université de Montréal (CHUM)

Collaborator